- Anti-counterfeit and consumer solutions provider YPB Group (YPB) secures its third MotifMicro1 (MM1) trial
- This third trial is with Israel-based company Latent Image Technology which is an established supplier of authentication and anti-counterfeit solutions
- MotifMicro1 is YPB’s smartphone-readable, anti-counterfeit technology that reads authentication marks on flat and curved surfaces
- YPB shares were steady at 0.3 cents
Anti-counterfeit and consumer solutions provider YPB Group (YPB) has secured its third MotifMicro1 (MM1) commercial trial.
The paid trial is with Israel-based company Latent Image Technology which is an established supplier of authentication and anti-counterfeit solutions to governments, pharma, fashion and automotive customers.
MotifMicro1 is YPB’s multi-patented, high security, smartphone-readable, anti-counterfeit technology which is invisible to the naked eye. It can read authentication marks on both flat and curved surfaces, making it accessible to a wide range of products.
The trial will run for 90 days with the revenue to be approximately $5,000 and if additional orders are placed beyond the trial period, a separate agreement will be negotiated.
YPB says paid commercial trials are a key element of its MM1 monetisation strategy and a way of confirming genuine interest from potential partners. It says the revenue to YPB from the trial with LIT will not be material but it could lead to significant opportunities.
“I’m delighted to sign our third MM1 trial partner. With Opal in Australia, Holographic Label in Malaysia and now LIT in Israel our commercial trial program is building both momentum and geographic reach with quality, high-volume, potential partners,” Executive Chairman John Houston said.
“As an established player in anti-counterfeit solutions, LIT’s interest in MM1 highlights the novelty of our technology and the potential leverage of our channel partner strategy to drive rapid market access.”
YPB was steady on the market with shares trading at 0.3 cents at 2:24 pm AEDT.